PT  - JOURNAL ARTICLE
AU  - Ssentongo, Paddy
AU  - Fronterre, Claudio
AU  - Geronimo, Andrew
AU  - Greybush, Steven J.
AU  - Mbabazi, Pamela K.
AU  - Muvawala, Joseph
AU  - Nahalamba, Sarah B.
AU  - Omadi, Philip O.
AU  - Opar, Bernard T.
AU  - Sinnar, Shamim A.
AU  - Wang, Yan
AU  - Whalen, Andrew J.
AU  - Held, Leonhard
AU  - Jewell, Chris
AU  - Muwanguzi, Abraham J. B.
AU  - Greatrex, Helen
AU  - Norton, Michael M.
AU  - Diggle, Peter
AU  - Schiff, Steven J.
TI  - Tracking and predicting the African COVID-19 pandemic
AID  - 10.1101/2020.11.13.20231241
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.13.20231241
4099  - http://medrxiv.org/content/early/2020/11/16/2020.11.13.20231241.short
4100  - http://medrxiv.org/content/early/2020/11/16/2020.11.13.20231241.full
AB  - The ongoing coronavirus disease 2019 (COVID-19) pandemic is heterogeneous throughout Africa and threatening millions of lives. Surveillance and short-term modeling forecasts are critical to provide timely information for decisions on control strategies. We use a model that explains the evolution of the COVID-19 pandemic over time in the entire African continent, parameterized by socioeconomic and geoeconomic variations and the lagged effects of social policy and meteorological history. We observed the effect of the human development index, containment policies, testing capacity, specific humidity, temperature and landlocked status of countries on the local within-country and external between-country transmission. One week forecasts of case numbers from the model were driven by the quality of the reported data. Seeking equitable behavioral and social interventions, balanced with coordinated country-specific strategies in infection suppression, should be a continental priority to control the COVID-19 pandemic in Africa.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a U.S. National Institutes of Health (NIH) Director's Transformative Award 1R01AI145057 (SJS). MMN was supported in part by the Covid Virus Seed Fund from the Institute for Computational and Data Sciences and the Huck Institute at the Pennsylvania State University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study relied on publicly available case data and did not require IRB oversight.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are in the public domain, and all code is open source and being made available at a public repository. https://github.com/Schiff-Lab/COVID19-HHH4-Africa